Ignite Creation Date:
2025-12-24 @ 7:52 PM
Ignite Modification Date:
2026-01-05 @ 6:19 PM
Study NCT ID:
NCT00660504
Status:
COMPLETED
Last Update Posted:
2014-07-18
First Post:
2008-04-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase3 Study of Amrubicin With Cisplatin Versus Etoposide-cisplatin for Extensive Disease Small Cell Lung Cancer
Sponsor:
Sumitomo Pharma (Suzhou) Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-04
Start Date Type:
None
Primary Completion Date:
2012-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-08
Completion Date Type:
ACTUAL
First Submit Date:
2008-04-10
First Submit QC Date:
None
Study First Post Date:
2008-04-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-11-21
Results First Submit QC Date:
None
Results First Post Date:
2014-07-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-07-09
Last Update Post Date:
2014-07-18
Last Update Post Date Type:
ESTIMATED